Emodin(1-)

Details

Top
Internal ID e79bd90f-d628-4f5b-98d6-84828fe9aaf3
Taxonomy Benzenoids > Anthracenes > Anthraquinones > Hydroxyanthraquinones
IUPAC Name 3,8-dihydroxy-6-methyl-9,10-dioxoanthracen-1-olate
SMILES (Canonical) CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3[O-])O
SMILES (Isomeric) CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3[O-])O
InChI InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3/p-1
InChI Key RHMXXJGYXNZAPX-UHFFFAOYSA-M
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H9O5-
Molecular Weight 269.23 g/mol
Exact Mass 269.04499838 g/mol
Topological Polar Surface Area (TPSA) 97.70 Ų
XlogP 3.40
Atomic LogP (AlogP) 1.26
H-Bond Acceptor 5
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
CHEBI:77659
3,8-dihydroxy-6-methyl-9,10-dioxoanthracen-1-olate
Q27147252
4,5-dihydroxy-7-methyl-9,10-dioxo-9,10-dihydroanthracen-2-olate

2D Structure

Top
2D Structure of Emodin(1-)

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9755 97.55%
Caco-2 + 0.7217 72.17%
Blood Brain Barrier - 0.8000 80.00%
Human oral bioavailability + 0.6000 60.00%
Subcellular localzation Mitochondria 0.8558 85.58%
OATP2B1 inhibitior - 0.7023 70.23%
OATP1B1 inhibitior + 0.9130 91.30%
OATP1B3 inhibitior + 0.9541 95.41%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9276 92.76%
P-glycoprotein inhibitior - 0.9081 90.81%
P-glycoprotein substrate - 0.9586 95.86%
CYP3A4 substrate - 0.5522 55.22%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8502 85.02%
CYP3A4 inhibition - 0.8205 82.05%
CYP2C9 inhibition + 0.7974 79.74%
CYP2C19 inhibition - 0.6971 69.71%
CYP2D6 inhibition - 0.7060 70.60%
CYP1A2 inhibition + 0.8898 88.98%
CYP2C8 inhibition - 0.8478 84.78%
CYP inhibitory promiscuity - 0.7993 79.93%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.7509 75.09%
Carcinogenicity (trinary) Non-required 0.5229 52.29%
Eye corrosion - 0.9877 98.77%
Eye irritation + 0.9629 96.29%
Skin irritation + 0.6152 61.52%
Skin corrosion - 0.9376 93.76%
Ames mutagenesis + 0.7800 78.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7863 78.63%
Micronuclear + 0.7900 79.00%
Hepatotoxicity + 0.8875 88.75%
skin sensitisation - 0.8947 89.47%
Respiratory toxicity + 0.5444 54.44%
Reproductive toxicity - 0.6556 65.56%
Mitochondrial toxicity - 0.5125 51.25%
Nephrotoxicity + 0.7875 78.75%
Acute Oral Toxicity (c) III 0.4821 48.21%
Estrogen receptor binding + 0.8091 80.91%
Androgen receptor binding + 0.6155 61.55%
Thyroid receptor binding - 0.7180 71.80%
Glucocorticoid receptor binding + 0.8971 89.71%
Aromatase binding - 0.5152 51.52%
PPAR gamma + 0.6853 68.53%
Honey bee toxicity - 0.9320 93.20%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 0.9800 98.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 95.98% 95.56%
CHEMBL2581 P07339 Cathepsin D 94.91% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 94.63% 91.49%
CHEMBL4208 P20618 Proteasome component C5 91.80% 90.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.00% 89.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 89.05% 99.23%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.30% 91.11%
CHEMBL3401 O75469 Pregnane X receptor 84.74% 94.73%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 83.66% 99.15%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 83.45% 90.71%
CHEMBL1929 P47989 Xanthine dehydrogenase 80.46% 96.12%

Cross-Links

Top
PubChem 25201450
NPASS NPC254848